The trial’s failure is a “stark reminder of just how elusive an HIV vaccine really is and why this kind of research continues to be important,” Jennifer Kates, director of global health and HIV policy at Kaiser Family Foundation, said.Original Article
HIV Vaccine In Late Stage Trial Fails, Extending Wait For Effective Jab
